Cannabidiol reduces withdrawal symptoms in nicotine-dependent rats

[1]  J. SHahinas,et al.  Dosage, Efficacy and Safety of Cannabidiol Administration in Adults: A Systematic Review of Human Trials , 2020, Journal of clinical medicine research.

[2]  H. Nisar,et al.  Smokeless tobacco use and risk of oral cavity cancer , 2020, Turkish journal of medical sciences.

[3]  J. A. Dani,et al.  Nicotine withdrawal. , 2020, Current topics in behavioral neurosciences.

[4]  O. George,et al.  Exposure to passive nicotine vapor in male adolescent rats produces a withdrawal-like state and facilitates nicotine self-administration during adulthood , 2019, European Neuropsychopharmacology.

[5]  I. Grant,et al.  Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath , 2019, Clinical chemistry and laboratory medicine.

[6]  I. Grant,et al.  Validation of a liquid chromatography-tandem mass spectrometry method for analyzing cannabinoids in oral fluid. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[7]  K. Janda,et al.  An enzymatic approach reverses nicotine dependence, decreases compulsive-like intake, and prevents relapse , 2018, Science Advances.

[8]  S. Edwards,et al.  Measuring Pain Avoidance‐Like Behavior in Drug‐Dependent Rats , 2018, Current protocols in neuroscience.

[9]  F. Carroll,et al.  New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice , 2018, Neuropharmacology.

[10]  J. Manzanares,et al.  Cannabidiol does not display drug abuse potential in mice behavior , 2018, Acta Pharmacologica Sinica.

[11]  D. Bagdas,et al.  Reversal of Nicotine Withdrawal Signs Through Positive Allosteric Modulation of &agr;4&bgr;2 Nicotinic Acetylcholine Receptors in Male Mice , 2018, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[12]  C. Morgan,et al.  The effects of cannabidiol on impulsivity and memory during abstinence in cigarette dependent smokers , 2018, Scientific Reports.

[13]  C. Morgan,et al.  Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal , 2018, Addiction.

[14]  L. Parsons,et al.  Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle , 2018, Neuropsychopharmacology.

[15]  K. Janda,et al.  An enzymatic advance in nicotine cessation therapy. , 2018, Chemical communications.

[16]  J. Manzanares,et al.  Cannabidiol reduces ethanol consumption, motivation and relapse in mice , 2018, Addiction biology.

[17]  A. Breland,et al.  Electronic Cigarette User Plasma Nicotine Concentration, Puff Topography, Heart Rate, and Subjective Effects: Influence of Liquid Nicotine Concentration and User Experience , 2017, Experimental and clinical psychopharmacology.

[18]  Y. Hurd,et al.  The endocannabinoid system as a target for addiction treatment: Trials and tribulations , 2017, Neuropharmacology.

[19]  M. Shoaib,et al.  Varenicline, the clinically effective smoking cessation agent, restores probabilistic response reversal performance during withdrawal from nicotine , 2017, Addiction biology.

[20]  L. Chan,et al.  Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products , 2016, Clinical Pharmacokinetics.

[21]  J. Prochaska,et al.  The Past, Present, and Future of Nicotine Addiction Therapy. , 2016, Annual Review of Medicine.

[22]  G. Koob,et al.  Extended access to nicotine leads to a CRF1 receptor dependent increase in anxiety‐like behavior and hyperalgesia in rats , 2015, Addiction biology.

[23]  A. Alberg,et al.  The 2014 Surgeon General's report: “The Health Consequences of Smoking–50 Years of Progress”: A paradigm shift in cancer care , 2014, Cancer.

[24]  Benjamin J. Whalley,et al.  Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders , 2014, Epilepsia.

[25]  N. Cimino,et al.  Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review , 2014, Drug metabolism reviews.

[26]  B. Sadek,et al.  Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors. , 2013, European journal of pharmacology.

[27]  A. Stinchcomb,et al.  Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder , 2013, Pharmacology Biochemistry and Behavior.

[28]  Sunjeev K Kamboj,et al.  Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings. , 2013, Addictive behaviors.

[29]  A. Duranti,et al.  Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition , 2011, PloS one.

[30]  R. Lukas,et al.  Effects of Hydroxymetabolites of Bupropion on Nicotine Dependence Behavior in Mice , 2010, Journal of Pharmacology and Experimental Therapeutics.

[31]  J. Martínez-Orgado,et al.  Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets , 2008, Pediatric Research.

[32]  A. Zuardi.  Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. , 2008, Revista brasileira de psiquiatria.

[33]  Joseph C. Cappelleri,et al.  Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt , 2008, Psychopharmacology.

[34]  R. Pertwee,et al.  Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro , 2007, British journal of pharmacology.

[35]  M. Sofuoglu,et al.  Bupropion for the treatment of nicotine withdrawal and craving , 2006, Expert review of neurotherapeutics.

[36]  J. Lake,et al.  Bupropion attenuates nicotine abstinence syndrome in the rat , 2006, Psychopharmacology.

[37]  C. Tränkle,et al.  Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors , 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.

[38]  E. Russo,et al.  Agonistic Properties of Cannabidiol at 5-HT1a Receptors , 2005, Neurochemical Research.

[39]  M. Cebeira,et al.  Cannabinoid tolerance and dependence: A review of studies in laboratory animals , 2005, Pharmacology Biochemistry and Behavior.

[40]  M. Damaj,et al.  Characterization of Spontaneous and Precipitated Nicotine Withdrawal in the Mouse , 2003, Journal of Pharmacology and Experimental Therapeutics.

[41]  J. Cryan,et al.  Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat , 2003, Psychopharmacology.

[42]  A. Markou,et al.  The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[43]  C. Simons,et al.  Analgesia induced by chronic nicotine infusion in rats , 2001, Psychopharmacology.

[44]  I. Stolerman,et al.  Plasma nicotine and cotinine levels following intravenous nicotine self-administration in rats , 1999, Psychopharmacology.

[45]  N. Benowitz,et al.  Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine , 1997, Clinical pharmacology and therapeutics.

[46]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[47]  J. Lake,et al.  Rodent model of nicotine abstinence syndrome , 1992, Pharmacology Biochemistry and Behavior.

[48]  C. Cohen,et al.  Cigarette smoking and addiction. , 1991, Clinics in chest medicine.

[49]  M. Stitzer,et al.  Smoking cessation and weight gain. , 1991, British journal of addiction.

[50]  C. Feyerabend,et al.  Plasma nicotine levels after cigarette smoking and chewing nicotine gum. , 1976, British medical journal.

[51]  Cannabidiol (Epidiolex) for epilepsy. , 2018, The Medical letter on drugs and therapeutics.

[52]  R. Papke,et al.  Varenicline and Cytisine Diminish the Dysphoric-Like State Associated with Spontaneous Nicotine Withdrawal in Rats , 2014, Neuropsychopharmacology.

[53]  D. Malin,et al.  Rodent models of nicotine withdrawal syndrome. , 2009, Handbook of experimental pharmacology.

[54]  M. Stitzer,et al.  Smoking relapse: the role of pharmacological and behavioral factors. , 1988, Progress in clinical and biological research.

[55]  J. Dolce.  Weight gain following smoking cessation. , 1986, Alabama medicine : journal of the Medical Association of the State of Alabama.